Damage to Brain Network Curbs Urge to Smoke

A study finds that injuries to certain areas of the brain were associated with quitting smoking more quickly, easily, and with no cravings.

| 2 min read
stubbed-out cigarette with smoke rising from ashes
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A study of people who effortlessly quit smoking after a stroke or other brain injury—and of those who suffered an injury but then kept smoking—has pinpointed a brain network involved in addiction, researchers reported June 13 in Nature Medicine. Experts say the findings may help identify targets for therapies that could treat addictions.

“I think this could be one of the most influential publications not only of the year, but of the decade,” A. Thomas McLellan, a professor emeritus of psychiatry at the University of Pennsylvania who also served as deputy director of the US Office of National Drug Control Policy, tells The New York Times. “It puts to rest so many of the stereotypes that still pervade the field of addiction: that addiction is bad parenting, addiction is weak personality, addiction is a lack of morality.” McLellan was not involved in the current research.

In the study, researchers compared the brain scans of 34 people who suddenly quit smoking following a focal brain injury, such as from a stroke, with those of 69 people who continued smoking after such an injury. Study coauthor Juho Joutsa of the University of Turku in Finland tells New Scientist that those who quit had damage to either the dorsal cingulate, the lateral prefrontal cortex, the insula, or to regions that were strongly connected to one of these areas via nerves. Together, these areas seem to comprise an addiction circuit, he tells the magazine. Looking at a separate cohort of 186 patients, the researchers also found that damage to this circuit was associated with a lower likelihood of alcohol addiction, indicating that the circuit may be implicated in addiction generally.

The results suggest that targeting the medial prefrontal cortex, a brain area that tamps down activity in the identified circuit, with transcranial magnetic stimulation might be a promising treatment avenue, Joutsa tells New Scientist. “What we’re realizing across many different fields is that our therapeutic targets are not brain regions, as we once thought, but connected brain circuits,” study coauthor Michael Fox of Harvard Medical School tells the Times. “If you take into account the way the brain is connected, you can improve treatment.”

But some experts tell the Times that there could be challenges to a brain stimulation-based approach, including figuring out which frequency of magnetic stimulation to use, the possibility that treatments would need to be individually tailored, and the challenge of making treatments consistently accessible to people with addictions.

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD
The Scientist Placeholder Image

Streamlining Microbial Quality Control Testing

MicroQuant™ by ATCC logo

Products

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

waters-logo

How Alderley Analytical are Delivering eXtreme Robustness in Bioanalysis